Adjuvant chemotherapy versus observation following radical cystectomy for locally advanced urothelial carcinoma of the bladder
-
Published:2022-06
Issue:6
Volume:40
Page:274.e15-274.e23
-
ISSN:1078-1439
-
Container-title:Urologic Oncology: Seminars and Original Investigations
-
language:en
-
Short-container-title:Urologic Oncology: Seminars and Original Investigations
Author:
Bharadwaj Maheetha,
Kaul Sumedh,
Fleishman AaronORCID,
Korets Ruslan,
Chang Peter,
Wagner Andrew,
Kim Simon,
Bellmunt JoaquimORCID,
Kaplan Irving,
Olumi Aria F.,
Gershman Boris
Reference23 articles.
1. Vale, Claire L., Adjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis of individual patient data Advanced Bladder Cancer (ABC) meta-analysis collaboration;Eur Urol,2005
2. Adjuvant chemotherapy with cisplatin and gemcitabine versus chemotherapy at relapse in patients with muscle-invasive bladder cancer submitted to radical cystectomy: an Italian, multicenter, randomized phase III trial;Cognetti;Ann Oncol,2012
3. Randomized phase III trial comparing adjuvant paclitaxel/gemcitabine/cisplatin (PGC) to observation in patients with resected invasive bladder cancer: Results of the Spanish Oncology Genitourinary Group (SOGUG) 99/01 study;Paz-Ares;J Clin Oncol,2010
4. Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3-pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial;Sternberg;Lancet Oncol,2015
5. Propensity-matched analysis of stage-specific efficacy of adjuvant chemotherapy for bladder cancer;Chen;Urol Oncol,2019
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献